Abstract: A system and method for passively testing a cardiac pacemaker in which sensing signal amplitudes and lead impedance values are measured and stored while the pacemaker is functioning in its programmed mode. The amplitude and impedance data may be gotten and stored periodically at regular intervals to generate a historical record for diagnostic purposes. Sensing signal amplitudes may also be measured and stored from a sensing channel which is currently not programmed to be active as long as the pacemaker is physically configured to support the sensing channel. Such data can be useful in evaluating whether a switch in the pacemaker's operating mode is desirable.
Type:
Grant
Filed:
November 14, 2006
Date of Patent:
June 1, 2010
Assignee:
Cardiac Pacemakers, Inc.
Inventors:
Vickie L. Conley, James O. Gilkerson, David L. Perschbacher
Abstract: Neuromodulation assemblies with lead bodies having curvatures that mimic the curvatures of the splenium, trunk, genu, or rostrum of the corpus callosum. Methods of stimulating the corpus callosum and methods of securing an electrical lead in the brain are also provided.
Abstract: A method and a multichannel implantable device are described for partial or complete restoration of impaired gastrointestinal motility, or for disturbing and/or partially or completely blocking normal gastrointestinal motility using one or multiple microsystem-controlled channels of circumferentially arranged sets of two or more electrodes which provide externally-invoked synchronized electrical signals to the smooth muscles via the neural pathways.
Abstract: As compared to conventional electrodes, the electrode configurations disclosed herein minimize irritation and damage to the skin when they are placed in contact with a patient's body over extended of time. The electrodes are formed from a conductive substrate coated with a thin dielectric material, and a plurality of open spaces pass through the electrodes. Those open spaces are distributed and sized to permit moisture on the surface of the patient's body to escape when the electrode is placed in contact with the patient's body. One intended use for the electrodes is for treating tumors by applying an AC electric field with specific frequency and field strength characteristics over an extended period of time.
Abstract: Certain embodiments of the present invention provide a catheter monitoring system including a catheter input module (CIM) adapted to be connected to at least one catheter, an amplifier base, and a host adapted to process data from the amplifier base. The CIM is adapted to be connected to an amplifier base during a study. The amplifier base is adapted to receive data from the CIM when the CIM is connected to the amplifier base.
Type:
Grant
Filed:
October 17, 2006
Date of Patent:
May 11, 2010
Assignee:
General Electric Company
Inventors:
Patrick Thomas Moran, Rodger F. Schmit, Daniel Richard Schneidewend
Abstract: Techniques are provided for improving cardiac output and also suppressing certain forms of apnea/hypopnea within a patient using an implantable medical device, such as a pacemaker or ICD. In one example, a selected pacing parameter—usually the pacing rate—is temporarily altered by an amount sufficient to elevate cardiac output, the elevation in cardiac output being eventually reduced by intrinsic compensatory mechanisms within the patient. The pacing parameter is then temporarily reset for a duration sufficient to allow the compensatory mechanisms to return toward a previous state so as to permit a subsequent alteration in the pacing parameter to again elevate cardiac output. The pacing parameter is repeatedly altered and reset so as to achieve an overall increase in cardiac output despite the intrinsic compensatory mechanisms. The increase in cardiac output is often sufficient to suppress certain forms of apnea/hypopnea, particularly apnea/hypopnea arising from Cheyne-Stokes Respiration (CSR).
Abstract: An ophthalmic treatment method for inhibiting death of retinal constitutive cells of an eye by stimulating the cells includes a first step of placing a positive electrode and a negative electrode in such positions outside the eye that the electrodes provide electrical stimulation to the cells, at least one of the electrodes being placed on one of a cornea and sclera of the eye; and a second step of generating an electrical stimulation pulse having an electric current set at 20 ?A or more but not exceeding 300 ?A from each placed electrode.
Abstract: A method and device for delivering anti-tachycardia pacing (ATP) therapy that includes an electrode to sense cardiac signals and to deliver the therapy, sensing circuitry, electrically coupled to the electrode, to detect the tachycardia event in response to the sensed cardiac signals, and a processor to control delivery of the therapy.
Abstract: A system and method recording sensing and pacing events in a cardiac rhythm management device. The method may be particularly useful in assessment of pacing parameters for ventricular resynchronization therapy.
Type:
Grant
Filed:
October 30, 2006
Date of Patent:
March 16, 2010
Assignee:
Cardiac Pacemakers, Inc.
Inventors:
Jeffrey E. Stahmann, Rene H. Wentkowski, Andrew P. Kramer, James Kalgren
Abstract: A lead of the present invention comprises an electrode array adapted to be stably anchored at a selected location within the vena cava of a human patient. The electrode array may take various shapes, including helical, annular and linear. The electrode array is connectable to an electrical stimulation means such as an implantable pulse or signal generator. Electrical stimulation applied to a selected region of the vena cava and across the wall of the vein, that is, transvascularly, to the vagus nerve or branches thereof, depolarizes the nerve to thereby effect control of the heart rate.
Type:
Grant
Filed:
May 2, 2005
Date of Patent:
March 9, 2010
Assignee:
Pacesetter, Inc.
Inventors:
Taraneh Ghaffari Farazi, Timothy A. Fayram
Abstract: A reinforced medical electrical lead for neurological applications has a reinforced construction for resisting the detachment of electrodes and lead connection terminals, thereby improving the robustness of the lead and extending the life of the lead by reducing the likelihood that a further surgical procedure will be required to remove the lead for repair or replacement thereof. The present reinforced lead construction maintains the integrity of the electrical connection between the conductor and the respective electrode and lead connection terminal by incorporating several reinforcing features in the lead construction in contrast to conventional lead constructions where it is possible to pull the electrodes and lead connection terminals away from their contact points with relatively little force.
Abstract: A system for stimulation includes an implantable pulse generator, a lead, and conductors. The lead includes an array body disposed at a distal end of the lead and electrodes concentrically arranged on the array body. A center electrode may also be disposed on the array body. The electrodes may be arranged in more than one concentric ring. A method of using an implantable stimulator includes implanting an implantable stimulator and providing an electrical signal to at least one electrode of the implantable stimulator to stimulate a tissue. The electrical signal may be provided between diametrically opposed electrodes or between electrodes that are not diametrically opposed. If the implantable stimulator has a center electrode, the electrical signal may be provided between the center electrode and at least one concentrically arranged electrode.
Type:
Grant
Filed:
March 31, 2006
Date of Patent:
March 2, 2010
Assignee:
Boston Scientific Neuromodulation Corporation
Abstract: An implantable device, such as an implantable medical device (IMD) includes at least two radio frequency (RF) antennas and may additionally include an RF communication circuit. The RF antennas are spatially diverse, are disposed adjacent a housing, and are each configured to receive RF signals transmitted to the IMD from a remote RF signal source. The RF communication circuit, if included, is disposed within the housing and is configured to selectively receive the RF signals received by one or more of the spatially diverse RF antennas.
Type:
Grant
Filed:
April 20, 2005
Date of Patent:
March 2, 2010
Assignee:
Medtronic, Inc.
Inventors:
Garry L. Dublin, Gregory J. Haubrich, Chris C. Fuller, Piotr Przybyszewski, Len D. Twetan, William D. Verhoef
Abstract: A system, method, or device classifies an arrhythmia according to the temporal order in which a depolarization wave associated with a particular heart contraction is received at a plurality of electrodes. One or more antiarrhythmia therapies is mapped to each arrhythmia classification. When a particularly classified arrhythmia is detected, the correspondingly mapped therapy list is selected and an appropriate antiarrhythmia therapy delivered. In one example, the particular therapy delivered in response to an arrhythmia depends at least in part on its historical success in treating arrhythmias of that classification.
Type:
Grant
Filed:
May 10, 2005
Date of Patent:
February 16, 2010
Assignee:
Cardiac Pacemakers, Inc.
Inventors:
Julio C. Spinelli, Qingsheng Zhu, Jeffrey E. Stahmann, Andrew P. Kramer
Abstract: One embodiment of the present invention provides a lead electrode assembly for use with an implantable cardioverter-defibrillator subcutaneously implanted outside the ribcage between the third and twelfth ribs comprising the electrode.
Type:
Grant
Filed:
May 5, 2006
Date of Patent:
February 2, 2010
Assignee:
Cameron Health, Inc.
Inventors:
Gust H. Bardy, Riccardo Cappato, William J. Rissmann, Gary H. Sanders
Abstract: An implantable medical device includes a control circuit for controlling the operation of the device and for obtaining physiological data from a patient in which the medical device is implanted. The implanted device also includes a communication circuit for transmitting the physiological data to an external device. A first power source is coupled to the control circuit and provides power to the control circuit. A second power source is coupled to the communication circuit and provides power to the communication circuit.
Abstract: Apparatus and methods are disclosed for inserting electrical leads within a heart. A method is provided for positioning a medical electrical lead in a cardiac vein. The method comprises inserting a lead within a coronary sinus, dispersing at least one vasodilating agent to dilate at least one cardiac vein, and inserting the lead into a dilated cardiac vein.
Abstract: A method of and a device for non-invasively measuring the hemodynamic state of a subject or a human patient involve steps and units of non-invasively measuring cardiac cycle period, electrical-mechanical interval, mean arterial pressure, and ejection interval and converting the measured electrical-mechanical interval, mean arterial pressure and ejection interval into the cardiac parameters such as Preload, Afterload and Contractility, which are the common cardiac parameters used by an anesthesiologist. The converted hemodynamic state of a patient is displayed on a screen as a three-dimensional vector with each of its three coordinates respectively representing Preload, Afterload and Contractility. Therefore, a medical practitioner looks at the screen and quickly obtains the important and necessary information.
Abstract: Methods and systems are directed to selecting from a variety of capture verification modes. A plurality of capture verification modes, including a beat by beat capture detection mode and a capture threshold testing mode without intervening beat by beat capture detection is provided. An efficacy of at least one of the capture verification modes is evaluated and, based on the evaluation, a capture verification mode is selected.
Type:
Grant
Filed:
June 28, 2005
Date of Patent:
February 2, 2010
Assignee:
Cardiac Pacemakers, Inc.
Inventors:
Alok Sathaye, Scott A. Meyer, Derek D. Bohn
Abstract: A seal adapted for use with medical devices is provided. The medical device may be a lead having a distal tip adapted for implantation on or about the heart and for connection to a system for monitoring or stimulating cardiac activity. The lead assembly in one embodiment includes an atraumatic tip. A seal is provided within the lead tip assembly, which prevents or limits further entry of fluids through the lead tip. The lead may be a left ventricular lead with a hemostasis mechanism provided therewithin.
Type:
Grant
Filed:
July 14, 2003
Date of Patent:
February 2, 2010
Assignee:
Cardiac Pacemakers, Inc.
Inventors:
Randy Westlund, Bruce Tockman, Gwen Crevensten, Lili Liu, Christopher M. Zerby